Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostics, and pharmacogenomic applications. The present application claims the benefit of U.S. Provisional Application Ser. No. 60/287,641 which was filed on Apr. 30, 2001 and is herein incorporated by reference in its entirety.